Key result
In patients with mechanical heart valves presenting with major hemorrhage, warfarin can safely be held off for one to two weeks with minimal risk of thromboembolism.
Why the study?
Guidelines are silent and data are limited regarding the safe resumption of anticoagulation and duration for holding therapy after major bleeding in patients with mechanical heart valves.
In patients with mechanical heart valves presenting with life-threatening bleeding, current literature suggests reversing coagulopathy with prothrombin complex concentrate and safely withholding warfarin for 1 to 2 weeks to minimize thromboembolic risk.
Findings hypothesis-generating for brief warfarin interruption in bleeding mechanical valve patients; prospective trials needed before practice change.
Valvular heart disease is common in the United States, with a number of patients undergoing valve replacement procedures every year. The two types of valve prostheses include mechanical and bioprosthetic valves. Mechanical heart valves require lifelong anticoagulation with vitamin K antagonists like warfarin. The clinicians are often faced with the dilemma of major bleeding episodes such as intracranial hemorrhage or gastrointestinal bleeding in these patients. The management includes reversing warfarin-induced coagulopathy with vitamin K supplementation, fresh frozen plasma, or prothrombin complex concentrate (PCC), with PCC being the treatment of choice. With regard to the safe resumption of anticoagulation, guidelines are silent, and data is limited to case reports/series. This article reviews the present literature for the management of bleeding in patients with mechanical heart valves and the safe duration for holding off anticoagulation with minimal risk of valve thrombosis/thromboembolism.
No takes yet. Share an insight, caveat, or question.
Huda et al. (2021) conducted a review in Mechanical heart valves with life-threatening bleeding. Holding anticoagulation and reversal agents (PCC, Vitamin K) was evaluated. In patients with mechanical heart valves presenting with major hemorrhage, warfarin can safely be held off for one to two weeks with minimal risk of thromboembolism.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: